New pharmacologic treatments for idiopathic chronic constipation: a financial strain for strainers

Gabrio Bassotti

doi:10.1080/17474124.2021.1913054

New pharmacologic treatments for idiopathic chronic constipation: a financial strain for strainers

Expert Rev Gastroenterol Hepatol. 2021 Jul;15(7):723-725. doi: 10.1080/17474124.2021.1913054. Epub 2021 Apr 12.

Author

Gabrio Bassotti^{1

2}

Affiliations

¹ Gastroenterology, Hepatology and Digestive Endoscopy Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
² Gastroenterology and Hepatology Unit, "Santa Maria della Misericordia" Hospital, Perugia, Italy.

PMID: 33798026
DOI: 10.1080/17474124.2021.1913054

No abstract available

Keywords: 5-HT4 agonists; Bile acid transport inhibitors; chronic constipation; costs; medical therapy; new drugs; prosecretory agents; treatment.

Publication types

Editorial
Review

MeSH terms

Chronic Disease
Constipation / drug therapy*
Constipation / economics
Constipation / etiology
Cost-Benefit Analysis
Gastrointestinal Agents / economics
Gastrointestinal Agents / therapeutic use
Humans
Laxatives / economics*
Laxatives / therapeutic use*
Serotonin 5-HT4 Receptor Agonists / economics
Serotonin 5-HT4 Receptor Agonists / therapeutic use

Substances

Gastrointestinal Agents
Laxatives
Serotonin 5-HT4 Receptor Agonists